Zevra Therapeutics (ZVRA) Shareholder's Equity (2014 - 2026)
Zevra Therapeutics (ZVRA) Shareholder's Equity (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
502.95 Mn |
| 10 |
Zevra Therapeutics |
796.95 Mn |
596.33 Mn |
34.30 Mn |
205.80 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
205.80 Mn |
| Dec 31, 2025 |
154.66 Mn |
| Sep 30, 2025 |
133.17 Mn |
| Jun 30, 2025 |
117.23 Mn |
| Mar 31, 2025 |
41.02 Mn |
| Dec 31, 2024 |
39.67 Mn |
| Sep 30, 2024 |
69.77 Mn |
| Jun 30, 2024 |
32.48 Mn |
| Mar 31, 2024 |
48.82 Mn |
| Dec 31, 2023 |
61.86 Mn |
| Sep 30, 2023 |
61.52 Mn |
| Jun 30, 2023 |
58.87 Mn |
| Mar 31, 2023 |
59.27 Mn |
| Dec 31, 2022 |
75.12 Mn |
| Sep 30, 2022 |
93.79 Mn |
| Mar 31, 2022 |
432.40 Mn |
| Dec 31, 2021 |
101.66 Mn |
| Sep 30, 2021 |
131.74 Mn |
| Jun 30, 2021 |
130.66 Mn |
| Mar 31, 2021 |
84.25 Mn |
